The conference will not only examine the good, the bad and the ugly facts about these ‘-oid’ agents but also give some empirical framework to educate us on the practicalities of ‘opioids, cannabinoids and gabapentinoids’. As usual, we will be offering up to date discussions with talks concerning the contemporaneous issues of these drugs from experts in this field.